1. Home
  2. AHT vs NXTC Comparison

AHT vs NXTC Comparison

Compare AHT & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHT
  • NXTC
  • Stock Information
  • Founded
  • AHT 2003
  • NXTC 2015
  • Country
  • AHT United States
  • NXTC United States
  • Employees
  • AHT N/A
  • NXTC N/A
  • Industry
  • AHT Real Estate Investment Trusts
  • NXTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AHT Real Estate
  • NXTC Health Care
  • Exchange
  • AHT Nasdaq
  • NXTC Nasdaq
  • Market Cap
  • AHT 26.2M
  • NXTC 24.6M
  • IPO Year
  • AHT 2003
  • NXTC 2019
  • Fundamental
  • Price
  • AHT $3.39
  • NXTC $10.14
  • Analyst Decision
  • AHT
  • NXTC Strong Buy
  • Analyst Count
  • AHT 0
  • NXTC 3
  • Target Price
  • AHT N/A
  • NXTC $23.00
  • AVG Volume (30 Days)
  • AHT 59.2K
  • NXTC 52.4K
  • Earning Date
  • AHT 11-04-2025
  • NXTC 11-05-2025
  • Dividend Yield
  • AHT N/A
  • NXTC N/A
  • EPS Growth
  • AHT N/A
  • NXTC N/A
  • EPS
  • AHT N/A
  • NXTC N/A
  • Revenue
  • AHT $1,119,102,000.00
  • NXTC N/A
  • Revenue This Year
  • AHT N/A
  • NXTC N/A
  • Revenue Next Year
  • AHT N/A
  • NXTC N/A
  • P/E Ratio
  • AHT N/A
  • NXTC N/A
  • Revenue Growth
  • AHT N/A
  • NXTC N/A
  • 52 Week Low
  • AHT $3.35
  • NXTC $2.69
  • 52 Week High
  • AHT $10.35
  • NXTC $15.96
  • Technical
  • Relative Strength Index (RSI)
  • AHT 14.14
  • NXTC 59.03
  • Support Level
  • AHT $3.35
  • NXTC $9.21
  • Resistance Level
  • AHT $4.50
  • NXTC $10.70
  • Average True Range (ATR)
  • AHT 0.21
  • NXTC 0.84
  • MACD
  • AHT -0.06
  • NXTC -0.08
  • Stochastic Oscillator
  • AHT 7.14
  • NXTC 100.00

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: